Trials / Completed
CompletedNCT02784197
cPSTA System CADLAD Study
Cardiac Phase Space Tomography Analysis (cPSTA) System: Coronary Artery Disease Learning and Development Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,622 (actual)
- Sponsor
- Analytics For Life · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study is primarily designed to collect resting phase signals from eligible subjects using the Phase Signal Recorder (PSR) prior to coronary angiography to machine learn and test an algorithm for detecting the presence of significant coronary artery disease in symptomatic adult patient.
Detailed description
This clinical protocol is primarily designed to collect resting phase signals from eligible subjects using the Phase Signal Recorder (PSR) prior to coronary angiography to machine learn and test an algorithm for detecting the presence of significant coronary artery disease in symptomatic adult patient. In addition to this primary objective, machine-learned algorithms will be developed and tested to report the left ventricular ejection fraction and to identify the location of significant coronary artery disease. The performance of the machine-learned algorithm will be evaluated using a comparative paired trial design. In this study, the physician will not be provided the results of analysis performed and, accordingly, the results of the analyses will not be used to guide treatment decisions for the patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Phase Signal Recorder | The cPSTA System is a medical device system that uses passive tomography to analyze a patient's phase space data to identify the presence of significant coronary artery disease. The cPSTA System consists of several components that work together to obtain, transmit, analyze the data, and display the results, including the Phase Signal Acquisition System (PSAQ System), which is the Phase Signal Recorder (PSR) and the Phase Signal Data Repository (PSDR); analytical software; and secure web portal. For this study only the PSAQ System is used by the clinical site for the purposes of acquiring and transmitting the signal. |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-12-01
- Completion
- 2018-05-01
- First posted
- 2016-05-27
- Last updated
- 2019-06-12
Source: ClinicalTrials.gov record NCT02784197. Inclusion in this directory is not an endorsement.